Anavex Life Sciences Corp. (AVXL)
1.82
-0.07
(-3.70%)
USD |
NASDAQ |
Oct 02, 16:00
1.815
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Market Cap : 168.71M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 168.71M |
| October 01, 2026 | 175.20M |
| September 30, 2026 | 187.25M |
| September 29, 2026 | 218.76M |
| September 28, 2026 | 217.84M |
| September 25, 2026 | 220.62M |
| September 24, 2026 | 216.91M |
| September 23, 2026 | 217.84M |
| September 22, 2026 | 228.96M |
| September 21, 2026 | 222.47M |
| September 18, 2026 | 224.33M |
| September 17, 2026 | 223.40M |
| September 16, 2026 | 218.76M |
| September 15, 2026 | 226.18M |
| September 14, 2026 | 241.01M |
| September 11, 2026 | 242.87M |
| September 10, 2026 | 246.57M |
| September 09, 2026 | 254.92M |
| September 08, 2026 | 264.19M |
| September 04, 2026 | 265.11M |
| September 03, 2026 | 264.19M |
| September 02, 2026 | 267.89M |
| September 01, 2026 | 266.04M |
| August 31, 2026 | 259.55M |
| August 28, 2026 | 277.16M |
| Date | Value |
|---|---|
| August 27, 2026 | 290.14M |
| August 26, 2026 | 300.34M |
| August 25, 2026 | 330.00M |
| August 24, 2026 | 288.21M |
| August 21, 2026 | 300.26M |
| August 20, 2026 | 290.06M |
| August 19, 2026 | 314.16M |
| August 18, 2026 | 296.55M |
| August 17, 2026 | 297.48M |
| August 14, 2026 | 298.40M |
| August 13, 2026 | 303.04M |
| August 12, 2026 | 316.01M |
| August 11, 2026 | 325.28M |
| August 10, 2026 | 314.16M |
| August 07, 2026 | 309.52M |
| August 06, 2026 | 303.96M |
| August 05, 2026 | 296.55M |
| August 04, 2026 | 291.92M |
| August 03, 2026 | 273.38M |
| July 31, 2026 | 254.85M |
| July 30, 2026 | 250.21M |
| July 29, 2026 | 230.75M |
| July 28, 2026 | 238.17M |
| July 27, 2026 | 231.68M |
| July 24, 2026 | 222.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sangamo Therapeutics, Inc. | 61.11M |
| Sarepta Therapeutics, Inc. | 1.848B |
| Anixa Biosciences, Inc. | 102.02M |
Market Cap Related Metrics
| Price to Book Value | 1.500 |
| Price | 1.82 |
| Earnings Yield | -8.33% |